Use of angiotensin II receptor blockers and the risk of acute pancreatitis: A nested case-control study

Pancreatology

Volumn 9, Issue 6, 2009, Pages 786-792

  Sjöberg Bexelius, Tomas ^a,c   García Rodríguez, Luis A ^b   Lindblad, Mats ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Centro Español de Investigación Farmacoepidemiologica ^*  (Spain)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute pancreatitis; Angiotensin I converting enzyme inhibitors; Angiotensin II receptor blocker; Case control study; The Health Improvement Network

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT;

ACUTE PANCREATITIS; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SMOKING; TREATMENT RESPONSE;

EID: 75149163983     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000225906     Document Type: Article

References (22)

1. Roberts SE, Williams JG, Meddings D, Goldacre MJ: Incidence and case fatality for acute pancreatitis in England: geographical variation, social deprivation, alcohol consumption and aetiology - a record linkage study. Aliment Pharmacol Ther 2008; 28: 931-941.
2. Andersson R, Andersson B, Haraldsen P, Drewsen G, Eckerwall G: Incidence, management and recurrence rate of acute pancreatitis. Scand J Gastroenterol 2004; 39: 891-894. (Pubitemid 39215462)
3. Whitcomb DC: Acute pancreatitis: molecular biology update. J Gastrointest Surg 2003; 7: 940-942. (Pubitemid 37524059)
4. Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S: Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007; 5: 648-661, 643. (Pubitemid 46830046)
5. Sundstrom A, Blomgren K, Alfredsson L, Wiholm BE: Acid-suppressing drugs and gastroesophageal reflux disease as risk factors for acute pancreatitis - results from a Swedish case-control study. Pharmacoepidemiol Drug Saf 2006; 15: 141-149.
6. Thisted H, Jacobsen J, Munk EM, Norgaard B, Friis S, McLaughlin JK, et al: Statins and the risk of acute pancreatitis: a populationbased case-control study. Aliment Pharmacol Ther 2006; 23: 185-190. (Pubitemid 43381182)
7. Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S: Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007; 5: 648-661, 663. (Pubitemid 46830046)
8. Blomgren KB, Sundstrom A, Steineck G, Wiholm BE: Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis. Diabetes Care 2002; 25: 298-302. (Pubitemid 41079625)
9. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V: Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy - Italian Group. N Engl J Med 1996; 335: 919-923.
10. Andriulli A, Leandro G, Federici T, Ippolito A, Forlano R, Iacobellis A, et al: Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007; 65: 624-632. (Pubitemid 46442832)
11. Tsujino T, Komatsu Y, Isayama H, Hirano K, Sasahira N, Yamamoto N, et al: Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol 2005; 3: 376-383. (Pubitemid 40488346)
12. Leung PS: The physiology of a local reninangiotensin system in the pancreas. J Physiol 2007; 580: 31-37.
13. Lai PB: Local renin-angiotensin system in the pancreas: the significance in acute pancreatitis. JOP 2001; 2: 13-15.
14. Tsang SW, Ip SP, Leung PS: Prophylactic and therapeutic treatments with AT1 and AT2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 2004; 36: 330-339.
15. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL: Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007; 16: 393-401. (Pubitemid 46656860)
16. Birck R, Keim V, Fiedler F, van der Woude FJ, Rohmeiss P: Pancreatitis after losartan. Lancet 1998; 351: 1178. (Pubitemid 28171827)
17. Bosch X: Losartan-induced acute pancreatitis. Ann Intern Med 1997; 127: 1043-1044.
18. Cheng RM, Mamdani M, Jackevicius CA, Tu K: Association between ACE inhibitors and acute pancreatitis in the elderly. Ann Pharmacother 2003; 37: 994-998. (Pubitemid 36875227)
19. Eland IA, Sundstrom A, Velo GP, Andersen M, Sturkenboom MC, Langman MJ, et al: Antihypertensive medication and the risk of acute pancreatitis: the European Case-Control Study on Drug-Induced Acute Pancreatitis (EDIP). Scand J Gastroenterol 2006; 41: 1484-1490. (Pubitemid 44764411)
20. Chan YC, Leung PS: Angiotensin II type 1 receptor-dependent nuclear factor- - B activation- mediated proinflammatory actions in a rat model of obstructive acute pancreatitis. J Pharmacol Exp Ther 2007; 323: 10-18.
21. Tsang SW, Cheng CH, Leung PS: The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul Pept 2004; 119: 213-219.
22. Tahmasebi M, Puddefoot JR, Inwang ER, Vinson GP: The tissue renin-angiotensin system in human pancreas. J Endocrinol 1999; 161: 317-322. (Pubitemid 29244259)